233 related articles for article (PubMed ID: 22957065)
1. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
[TBL] [Abstract][Full Text] [Related]
5. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Wong SC; Willis NS; Craig JC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
Lin W; Li HY; Lin S; Zhou T
Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
Qiu TT; Zhang C; Zhao HW; Zhou JW
Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive agents in the treatment of IgA nephropathy: A meta-analysis of clinical randomized controlled literature.
Zheng J; Gong X; Wu Z
Niger J Clin Pract; 2020 Apr; 23(4):437-449. PubMed ID: 32246648
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
Medicine (Baltimore); 2021 Jul; 100(28):e26628. PubMed ID: 34260552
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.
Chen Y; Schieppati A; Cai G; Chen X; Zamora J; Giuliano GA; Braun N; Perna A
Clin J Am Soc Nephrol; 2013 May; 8(5):787-96. PubMed ID: 23449768
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis.
Dai P; Xie W; Yu X; Sun J; Wang S; Kawuki J
Int Immunopharmacol; 2021 May; 94():107376. PubMed ID: 33582591
[TBL] [Abstract][Full Text] [Related]
13. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
15. Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis.
Santosh T; Liu H; Liu B
Chin Med J (Engl); 2014; 127(14):2693-9. PubMed ID: 25043091
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis.
Li YC; Huang J; Li X; Zhao SM
Nefrologia (Engl Ed); 2019; 39(3):269-276. PubMed ID: 30755327
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review.
Perna A; Schieppati A; Zamora J; Giuliano GA; Braun N; Remuzzi G
Am J Kidney Dis; 2004 Sep; 44(3):385-401. PubMed ID: 15332211
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.
Huang H; Liang Z; Zheng X; Qing Q; Du X; Tang Z; Wei M; Wang C; Zhong Q; Lin X
Ren Fail; 2021 Dec; 43(1):840-850. PubMed ID: 34016023
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
Peng L; Wei SY; Li LT; He YX; Li B
J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
